Bruin Carly Daniels, who leads the Pfizer scientists developing vaccines for pneumonia and the coronavirus, always remembers that patients are waiting.
The five-year award from California’s stem cell agency will help prepare young scientists and physicians to become leaders in the regenerative medicine field.
Research brief: Scientists have identified hundreds of chemical modifications that can alter RNA’s protein-making instructions without affecting the core DNA.
UCLA researchers found that previously infected people produced a vigorous antibody response similar to a severe natural infection after just one shot.
Research brief: A UCLA team has demonstrated that altering a key molecule used in the therapy yields superior and longer-lasting results in mouse models.
Both vaccinated and non-vaccinated personnel will be tested to gauge how well the vaccines prevent infections and lessen their impact when they do occur.